AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06203561 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent Oro-esophageal Tube Feeding
Description: The observation group was given enteral nutritional support with Intermittent Oro-esophageal Tube Feeding according to the following procedure: Before each feeding, inside and outside of the tube was cleaned with water. During feeding, the patient should maintain a semi-reclining or sitting position with mouth opened, and the tube was inserted slowly and smoothly into the upper part of the esophagus by medical staffs while the appropriate depth of intubation was checked with the calibration markings on the tube wall. The distance from the incisors to the head part of the tube should be between 22-25 cm. However, the specific depth should be evaluated based on patients' feedback and adjusted accordingly. After insertion, the tail part of the tube should be put into a container full of water and the absence of continuous bubbles indicated a successful intubation. Then, the feeding was to be conducted three times per day with 50 ml per minute and 400-600ml for each feeding.
Study NCT06203561 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Nasogastric Tube Feeding
Description: The control group was given enteral nutritional support with Nasogastric Tube Feeding according to the relevant guidelines. Within 4 hours after admission, the placement of the feeding tube was conducted by professional medical staffs and after intubation, the tube was secured to the patient\&#39;s cheek with medical tape. The feeding was conducted once every 3-4 hours, with 200-300ml each time. The total feeding volume was determined based on daily requirements. The feeding content was formulated by the nutritionists based on the patient\&#39;s condition and relevant guidelines to reach the energy demand as 20-25 kcal/kg/day and protein supplementation of 1.2-2.0 g/kg/day for both two groups. For patients with limited tube feeding compliance, we made appropriate adjustments to ensure that they were not at risk of severe malnutrition as much as possible.
Study NCT05870943 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hybrid Argon Plasma Coagulation
Description: Hybrid APC will be utilized to first ablate the gastric mucosa along the greater curve of the stomach.
Study NCT05870943 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endoscopic Sleeve Gastroplasty
Description: Endoscopic full-thickness tissue acquisition and plication using 2-0 Prolene synthetic sutures via the Apollo ESG platform.
Study NCT05870943 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic Sleeve Gastroplasty
Description: Endoscopic full-thickness tissue acquisition and plication using 2-0 Prolene synthetic sutures via the Apollo ESG platform.
Study NCT04901689 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Leronlimab
Description: Leronlimab 700 mg
Study NCT04901689 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05744804 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: -group of patients(75 patients) will receive low dose rivaroxaban myocardial infarction plus (acetylsalicylic acid 75 mg and clopidogrel 75 mg
Description: receive low dose rivaroxaban (rivaroxaban 2.5 mg twice daily orally) for 1 month after anterior ST-segment myocardial infarction plus dual antiplatelet therapy (acetylsalicylic acid 75 mg once daily orally and clopidogrel 75 mg once daily orally)
Study NCT05744804 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: (acetylsalicylic acid 75 mg once daily orally and clopidogrel 75 mg once daily orally only)
Description: control group of patients: 75 Patients of anterior ST-segment myocardial infarction on dual antiplatelet therapy only
Study NCT04587609 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Free Phone Mounts
Description: Participants will receive free phone mounts
Study NCT04587609 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Commitment Contract
Description: Participants will develop and sign a personalized commitment contract where they will create their own weekly goals for phone use reduction, and plan potential future obstacles that may hinder them from reaching their goal and how and plan to overcome that obstacle.
Study NCT04587609 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Personalized Habit Tips
Description: Participants will receive weekly habit formation tips by text message. These messages will be tailored to encourage use of phone mounts, setting up do not disturb while driving, and include their personal obstacles and plans they developed to overcome.
Study NCT04587609 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Social Gamification Feedback
Description: Each week of the intervention period, the participant will be notified whether they met their prior week's goal, stayed about the same, or backslid. Participants will all start with 100 points, and can gain/maintain/lose points each week in the intervention period. Levels are as follows:~Copper: 0-40 points Bronze: 50-80 points Silver: 90-120 points Gold: 130-160 points Platinum: 170-200 points~Social competition: participants will be placed in groups of 10 based on similarity of baseline phone use. Weekly leaderboard reports will be sent via email, with SMS reminder. In the leaderboard they'll see themselves as You.
Study NCT04587609 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Contest Financial Incentives
Description: Participants who finish in the platinum level will receive equal share of a prize, or a small amount will be awarded each week over the course of the intervention period to the weekly Safest Driver in each of the social competition cohorts.
Study NCT04401683 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Home-based rehabilitation with a digital biofeedback system
Description: Participants in the experimental group will perform a 12-week digital exercise program, to be performed independently at home using the SWORD Phoenix® medical device, under remote monitoring from a physical therapist.~Additionally, both groups will have access to standard medical treatments and to an educational program, specifically developed to target chronic low back pain, consisting of a booklet containing pathology-related information, causes, treatment recommendations, as well as suggestions of cognitive behavioural therapy exercises.
Study NCT04401683 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional home-based rehabilitation
Description: Participants in the control group will benefit from a 12-week home-based rehabilitation program, consisting of 12 face-to-face sessions (1 per week) with a physical therapist, complemented by additional non-supervised sessions. Both supervised and unsupervised sessions will follow the same set of exercises defined for the experimental group.~Additionally, both groups will have access to standard medical treatments and to an educational program, specifically developed to target chronic low back pain, consisting of a booklet containing pathology-related information, causes, treatment recommendations, as well as suggestions of cognitive behavioural therapy exercises.
Study NCT05282134 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Wet cupping therapy
Description: Wet cupping therapy is a bloodletting application done by cups on the skin
Study NCT05282134 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: Acupuncture is a complementary application of TCM done by needles
Study NCT06259656 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: COVID-19 Spike Protein IgG Quantitative Antibody (CMIA)
Description: Maternal blood and cord blood were collected to test for COVID-19 Spike Protein IgG Quantitative Antibody (CMIA)
Study NCT05721599 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Integrated care with nutrition and lifestyle counselling
Description: The structured care includes specialist care, integrated assessment, group health education, one-on-one nutrition and lifestyle guidance, online and face-to-face support group and case management.
Study NCT05242198 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Robotic prostatectomy
Description: patients who will undergo robotic prostatectomy
Study NCT06197919 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: postural exercises
Description: In this study forward head posture will be defined as CVA\<49°, which was diagnosed by photogrammetry method.~The postural exercise program consisted of two strengthening (deep cervical flexors and shoulder retractors) and two stretching (cervical extensors and pectoral muscles) exercises based on Kendall et al's approach. The exercises involved~1. chin tucks ins~2. a chin drop in sitting~3. shoulder retraction~4. unilateral and bilateral pectoralis stretches Participants were instructed to complete 3 sets of 12 repetitions of the strengthening exercises and 3 stretching exercises held for 30 seconds each. This program was to be repeated 4 times per week. They also returned for a consultation every 2 weeks to be checked for exercise technique and progression, if appropriate. Progress to the next exercise level was indicated if the participant could complete 12 repetitions, 3 times easily with correct form
Study NCT06197919 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: postural exercises with breathing exercises
Description: The postural exercise program consisted the exercises i.e chin tucks in, a chin drop in sitting, shoulder retraction. Participants were instructed to complete 3sets of 12repetitions of these exercises. This program was to be repeated 4times per week. They also returned for a consultation every 2weeks to be checked for exercise technique and progression, if appropriate. Progress to the next exercise level was indicated if the participant could complete 12repetitions, 3times easily with correct form.~For the breathing exercises in experimental group, breathing program includes respiratory muscle training, relaxation techniques, breathing techniques, e.g., deep breathing, hand controlled diaphragmatic breathing, relaxation technique, deep breathing, controlled diaphragmatic breathing, slow relaxed exhalation with pursed lips technique, and segmental breathing techniques. exercise protocol will be continued for 6 weeks with and initial, after 3weeks and final assessment of pain and CVA.
Study NCT06164990 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PEKK framework
Description: PEKK (Pekkton) framework in mandibular implant-supported complete fixed dental prostheses with All-on-four treatment concept
Study NCT04854837 — intervention group
Intervention type: DRUG
Intervention: Remdesivir
Description: Remdesivir treatment
Study NCT05318391 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Gene expression profile
Description: Diagnostic Test:~The Canhelp-COO Assay (Canhelp Genomics CO., Ltd) for differentiating COO subtypes using gene expression analysis by real-time PCR (RT-PCR)
Study NCT06128460 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zimberelimab
Description: 240mg, q3w，8 cycles
Study NCT06128460 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Platinum
Description: cisplatin 40mg/m2 for 5-6 cycles
Study NCT06128460 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiotherapy
Description: 45-50Gy/1.8Gy/25-28f
Study NCT05518747 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic
Description: In this group participants will receive probiotic supplements twice a day (morning and evening) for a period of 12 weeks.
Study NCT05518747 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: In this group participants will receive placebo twice a day (morning and evening) for at period of 12 weeks.
Study NCT05430633 — intervention group
Intervention type: PROCEDURE
Intervention: Appendectomy
Description: Appendectomy - laparoscopic or open
Study NCT05383027 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Music Listening Control (MLC)
Description: MLC participants will engage in assigned music listening in the presence of their loved one with ADRD via a selected online platform (pandora or Spotify) for 10 minutes a day 5-7 days a week.
Study NCT05383027 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Heart Focused Breathing
Description: Heart-focused breathing participants will engage in heart-focused breathing using the inner balance device (shipped to their home), they will be asked to do this in the presence of their loved one with ADRD for 10 minutes a day 5-7 days per week.
Study NCT04952064 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Monosialoganglioside GM1
Description: Monosialoganglioside GM1 diluted with 0.9% normal saline 100ml, iv, daily for 12-14 days
Study NCT06329583 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: diaphragmatic breathing
Description: Different positions and techniques for diaphragmatic breathing
Study NCT06327841 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: sesame oil
Description: 15min of oil pulling with 15ml sesame oil for 8 weeks
Study NCT06327841 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: distilled water
Description: 15min rinsing with 15ml distilled water for 8 weeks
Study NCT04728516 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vonoprazan-based dual eradication therapy for two weeks
Description: Patients with ACS after PCI, associated with positive Hp need a long-term DAPT treatment. We conducted a study on the prevention of gastrointestinal bleeding between vonoprazan-based dual eradication therapy for two weeks and pantoprazole for six months of a rountine therapy.
Study NCT04728516 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: amoxicillin
Description: amoxicillin
Study NCT04728516 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pantoprazole
Description: Pantoprazole
Study NCT05650918 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MesoPher
Description: autologous monocyte-derived dendritic cells loaded with PheraLys (tumor cell lysate)
Study NCT05650918 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Mitazalimab
Description: agonistic human monoclonal (IgG1) antibody targeting CD40
Study NCT05417724 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Battlefield Acupuncture
Description: Battlefield Acupuncture
Study NCT05517941 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: active cycle breathing
Description: The active cycle breathing technique will involve three steps: breathing control, thoracic expansion exercise, and forced expiration technique, In breathing control, the patient will sit comfortably in a chair and breathe at a normal rate and depth using the lower chest. In the thoracic expansion exercise, the physical therapist rested his/her hands on the patient's epigastrium and guided the patient's breathing so that they breathed at a slow and deep rate using the lower chest, then held their breath for 2 s and fully exhaled; this was repeated two or three times, then the patient returned to breathing control. For the forced expiration technique, the physical therapist asked the patient to inhale deeply while simultaneously contracting the abdominal muscle and keeping the mouth and throat open. They then held their breath for 2 s, followed by vigorous exhalation
Study NCT05517941 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: incentive spirometer
Description: Incentive spirometry is accomplished by using a device that provides feedback when the patient inhales at a predetermined flow and sustains the inflation for at least 5 seconds. The patient is instructed to hold the spirometer in an upright position, exhale normally, and then place the lips tightly around the mouthpiece. The next step is a slow inhalation to raise the ball (flow-oriented) or the piston/ plate (volume-oriented) in the chamber to the set target. At maximum inhalation, the mouthpiece is removed, followed by a breath-hold and normal exhalation.
Study NCT06437743 — intervention group
Intervention type: DEVICE
Intervention: Nociception Level (NoL) Monitor
Description: The NoL Monitor (PMD-200) is a multi-parameter sensor device placed on the patient's finger to estimate nociception levels during surgery. It provides continuous, real-time feedback to the anesthesiologist on the patient's nociception, assisting in the optimization of analgesic drug administration. The monitor integrates parameters such as heart rate variability, skin conductance, and other physiological signals to compute the NoL index, which ranges from 0 to 100, with target values between 10 and 25 for optimal nociception management.
Study NCT05376332 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sonomyographic Prosthesis
Description: The sonomyographic system will include a custom-fitted test socket incorporating ultrasound transducers and controlling a TASKA prosthetic hand. All socket fittings will be performed by a board-certified prosthetist as part of this study.
Study NCT05376332 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Myoelectric direct control prosthesis
Description: The direct control system will include a custom-fitted test socket incorporating dual-site electrodes and controlling a TASKA prosthetic hand. All socket fittings will be performed by a board-certified prosthetist as part of this study.
Study NCT05376332 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Myoelectric pattern recognition prosthesis
Description: The pattern recognition system will include the subject's clinically-prescribed socket and commercially-available pattern recognition technology (IBT Sense). The pattern recognition system will not be fitted as part of this study, as subjects will already be trained users prior to enrolling in the study.
Study NCT04945057 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mindpax monitoring system
Description: All participants will use the Mindpax mobile application, wear the wrist accelerometer and fill in weekly self-assessments. All participants will obtain weekly health tips (general psychoeducation) and additional individualized targeted tips when the system detects deviation from individual mood, activity and sleep patterns, during the active 12 months of followup.
Study NCT04824651 — intervention group
Intervention type: BIOLOGICAL
Intervention: COVID-19 vaccine
Description: Vaccination done as part of France's COVID-19 Vaccination Campaign
Study NCT05857475 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CPAP therapy
Description: Continous positive airway pressure therapy
Study NCT05857475 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: No CPAP
Study NCT04495608 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluconazole
Description: Fluconazole 50 mg/capsule or placebo, per os during 18 weeks :~* From W0 to W2 : 1 caps/ day~* From W2 to W4 : 1 or 2 caps/day~* From W4 to W6 : 1, 2 or 3 caps/day~* From W6 to W18 : 1, 2, 3 or 4 caps/day~The number of capsules to take will be determined by 24-hours calciuria results performed every 2 weeks during the titration period (W2, W4 and W6).~During the titration period, if 24-hours calciuria is > 0.1 mmol/kg/day, fluconazole dose will be increased every 2 weeks to 50 mg per intake, with a maximum dose of 200 mg/day. If 24-hour calciuria is ≤ 0.1mmol/kg/day, fluconazole dose will remain stable.~After W6 and until the end of the study, the treatment dose will remain stable (stable period).
Study NCT04495608 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo (1, 2, 3 or 4 pills to take daily during 18 weeks), same appearance to experimental drug
Study NCT06451198 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indobufen
Description: Patients meeting the criteria are randomized before discharge from the hospital and given indobufen 100mg bid and ticagrelor 90mg bid the second day after randomization. The administration shall last 12 months.
Study NCT06451198 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aspirin
Description: Patients meeting the criteria are randomized before discharge from the hospital and continued aspirin 100 mg qd and ticagrelor 90mg bid. The administration shall last 12 months.
Study NCT06451198 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ticagrelor
Description: All the patients meeting the criteria and enrolled in the study are given ticagrelor 90mg bid for 12 months.
Study NCT06451198 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Description: All the patients meeting the criteria and enrolled in the study are given ticagrelor 90mg bid for 12 months.
Study NCT06464783 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Comprehensive Corrective Exercise Program
Description: Week 1st to 2nd: Corrective exercises +Core strengthening (2 sets 10 reps). Stretchings (30 sec hold, 3 reps).~Week 3rd to 5th: Corrective exercises +Core strengthening (3 sets 15 reps). Stretchings (30 sec hold, 3 reps).~Week 5th to 8th: Corrective exercises +Core strengthening (3 sets 20 reps). Stretchings (30 sec hold, 3 reps).
Study NCT06464783 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Thoracic Exercise Program
Description: Week 1st to 2nd: Thoracic extension (2 sets 10 reps). Mobilization (60 sec 2 reps). Stretching (30 sec hold and 3 reps).~Week 3rd to 5th: Thoracic extension (2 sets 15 reps). T W Y I thoracic exercise in prone (2 sets 15 reps). Self-mobilization (60 seconds 2 reps). Stretching (30 sec hold and 3 reps)~Week 5th to 8th. Thoracic extension (3 sets 20 reps). T W Y I thoracic exercise in prone position (3 sets 20 reps). Self-mobilization (60 sec 2 reps). Stretching (30 sec hold and 3 reps)